|
CTCFL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.549600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.335400E-01 |
| Normal-vs-Stage2 |
9.580400E-01 |
| Normal-vs-Stage3 |
2.673900E-02 |
| Normal-vs-Stage4 |
2.007400E-04 |
| Stage1-vs-Stage2 |
6.152600E-01 |
| Stage1-vs-Stage3 |
2.130200E-01 |
| Stage1-vs-Stage4 |
1.620720E-03 |
| Stage2-vs-Stage3 |
3.989000E-01 |
| Stage2-vs-Stage4 |
2.091000E-01 |
| Stage3-vs-Stage4 |
2.034800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.394300E-02 |
| Normal-vs-AfricanAmerican |
5.011600E-01 |
| Normal-vs-Asian |
6.806000E-01 |
| Caucasian-vs-AfricanAmerican |
3.312600E-01 |
| Caucasian-vs-Asian |
4.133000E-01 |
| AfricanAmerican-vs-Asian |
5.187200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.096100E-02 |
| Normal-vs-Female |
2.539200E-01 |
| Male-vs-Female |
2.702000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.585600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.431800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.908100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.682100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.449450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.440000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.263800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.157400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.802400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.846000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.670640E-01 |
| Normal-vs-Grade 2 |
7.073000E-01 |
| Normal-vs-Grade 3 |
1.399100E-03 |
| Normal-vs-Grade 4 |
3.678900E-03 |
| Grade 1-vs-Grade 2 |
5.100200E-02 |
| Grade 1-vs-Grade 3 |
2.740400E-03 |
| Grade 1-vs-Grade 4 |
3.248200E-04 |
| Grade 2-vs-Grade 3 |
8.195400E-03 |
| Grade 2-vs-Grade 4 |
1.173510E-02 |
| Grade 3-vs-Grade 4 |
5.184400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.796400E-01 |
| Normal-vs-ccB subtype |
2.897700E-03 |
| ccA subtype-vs-ccB subtype |
9.700500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.758080E-02 |
| Normal-vs-N1 |
3.012400E-02 |
| N0-vs-N1 |
3.105600E-01 |
|
|
